Disease progression from infection to Aids follows a set pattern in most infected individuals, although the rate of disease progression varies from one person to the other. Disease progression from infection to Aids follows a set pattern in most infected individuals, although the rate of disease progression varies from one person to the other. Rapid…
Notable improvement in brain cancer survival among younger patients but not much for elderly
Glioblastoma is the most common brain cancer, and one of the deadliest cancers known. Unfortunately, there is no cure for these rapidly progressing tumors. A randomized controlled trial in 2005 showed that a new chemotherapy (temozolomide) given at the same time with radiation therapy increased survival from 12.1 to 14.6 months in 18 to 70-year-old…
Using Chinese Medicine to Sharpen Your Brain
Do you forget things? Do you need a few cups of coffee in the morning to stay on task? Have you ever walked into a room and wondered why you were there? If so, you’re not alone. Chinese Medicine, a 2500 year old medical system, can help; as it has shown to decrease symptoms of…
Biochemists Discover A New Target For Patients With Diabetes
Focusing on a simple hormone in us all, a Yale researcher has found specific forms of it that poke toxic holes in cells — a discovery that he is leveraging into a treatment for patients with diabetes. 12th International Conference on Pharmaceutical Chemistry during May 20-21, 2019 at Berlin, Germany. The conference emphasizes the theme…
Experts working to globalise ayurveda research and education
International scientists along with experts from the Arya Vaidya Pharmacy and Research Foundation are working on policy recommendations towards globalising and standardising ayurveda research and education across countries. The outcome of the deliberations would be submitted to the government for further perusal, said P R Krishnakumar, head of AVP group of institutions Stating that the…
Half of all women are at risk of a stroke, dementia or Parkinson’s disease says study
According to a new study from Dutch researchers, one in two women and one in three men are at risk of developing degenerative neurological illnesses such as dementia, Parkinson’s disease or stroke over their lifetime. He added that if the causes of these diseases overlap, prevention strategies and treatments could also overlap. Some of the…
Promising new class of antibodies protects against HIV-1 infection
A group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the virus that causes AIDS. Led by Ruth Ruprecht, M.D., Ph.D., the team used an animal model to show for the first time that an antibody called Immunoglobulin M (IgM) was effective in preventing infection after mucosal…
To Get the Flu Shot or Not?
What is the Flu Shot? The flu shot is an inactivated version of the influenza virus that protects against projected strains of the virus. The vaccine pushes the body to develop antibodies to the given virus about two weeks after receiving the shot. Influenza can be life-threatening, especially for very young children, the elderly, and immune-compromised patients, so many…
Viral immunotherapy shows promise to treat pediatric brain tumors
A viral immunotherapy using a herpes virus to treat brain tumors has been shown to be safe and well-tolerated in a pediatric study from the University of Alabama at Birmingham and Children’s of Alabama. The findings, presented today at the International Symposium on Pediatric Neuro-Oncology in Denver, also showed preliminary evidence of effectiveness in killing…
£500,000 grant could pave way for new antibiotic to battle against drug-resistant superbugs
A new antibiotic hailed as the “last line of defense” in the battle against drug-resistant superbugs such as MSRA and VRE is taking the next step in development thanks to a UK Government grant of almost £500,000. 12th International Conference on Pharmaceutical Chemistry during May 20-21, 2019 at Berlin, Germany. The conference emphasizes the theme…
